Feb 24, 2023
1:4
For every 4 shares held, investors received 1. The price per share adjusted from $6.32 to $25.28.
The split itself did not change the total investment value.
Enliven Therapeutics, Inc. (NASDAQ:ELVN) operates in the Biotechnology industry.
Enliven Therapeutics, Inc. company overviewEnliven Therapeutics, Inc.'s most recent stock split was on February 24, 2023. It was a 1-for-4 reverse split, so shareholders received 1 share for every 4 they held.
Enliven Therapeutics, Inc. has split its stock once. This history records one reverse split, on February 24, 2023.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Enliven Therapeutics, Inc.'s 1-for-4 reverse split on February 24, 2023, every 4 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Enliven Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on February 24, 2023, 3 years ago. Companies announce splits in advance, and any new NASDAQ:ELVN split will appear on this page.